FDA Product Code QEP: Nucleic Acid Detection System For Non-viral Microorganism(s) Causing Sexually Transmitted Infections
Rapid molecular identification of non-viral pathogens enables targeted antimicrobial therapy. FDA product code QEP covers nucleic acid detection systems for non-viral microorganisms including bacteria, fungi, and parasites.
These PCR-based or hybridization assays detect and identify pathogen-specific nucleic acid sequences from clinical specimens including blood, respiratory samples, and body fluids, providing results faster than conventional culture methods.
QEP devices are Class II medical devices, regulated under 21 CFR 866.3393 and reviewed by the FDA Microbiology panel.
Leading manufacturers include Roche Molecular Systems, Inc., Hologic, Inc. and Binx Health, Inc..
FDA 510(k) Cleared Nucleic Acid Detection System For Non-viral Microorganism(s) Causing Sexually Transmitted Infections Devices (Product Code QEP)
About Product Code QEP - Regulatory Context
510(k) Submission Activity
23 total 510(k) submissions under product code QEP since 2019, with 22 receiving FDA clearance (average review time: 239 days).
Submission volume has increased in recent years - 6 submissions in the last 24 months compared to 3 in the prior period - suggesting growing market activity in this device classification.
FDA 510(k) Review Time - QEP Product Code
FDA review times for QEP submissions have been consistent, averaging 229 days recently vs 242 days historically.
QEP devices are reviewed by the Microbiology panel. Browse all Microbiology devices →